Functional And Survival Outcome Of Egyptian Children And Adolescents With Malignant Bone Tumors: An Experience In A Setting Of Limited Health Resource

[1]Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J: Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009. Pediatrics 2014, 134(4):e945-955.SiegelDAKingJTaiEBuchananNAjaniUALiJCancer incidence rates and trends among children and adolescents in the United States, 2001-2009Pediatrics20141344e94595510.1542/peds.2013-3926453680925201796Search in Google Scholar

[2]Heare T, Hensley MA, Dell’Orfano S: Bone tumors: osteosarcoma and Ewing’s sarcoma. Current opinion in pediatrics 2009, 21(3):365-372.HeareTHensleyMADell’OrfanoSBone tumors: osteosarcoma and Ewing’s sarcomaCurrent opinion in pediatrics200921336537210.1097/MOP.0b013e32832b111119421061Search in Google Scholar

[3]Mirabello L, Troisi RJ, Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009, 115(7):1531-1543.MirabelloLTroisiRJOsteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramCancer200911571531154310.1002/cncr.24121281320719197972Search in Google Scholar

[4]Luetke A, Meyers PA, Lewis I, Juergens H: Osteosarcoma treatment - where do we stand? A state of the art review. Cancer treatment reviews 2014, 40(4):523-532.LuetkeAMeyersPALewisIJuergensHOsteosarcoma treatment - where do we stand? A state of the art reviewCancer treatment reviews201440452353210.1016/j.ctrv.2013.11.00624345772Search in Google Scholar

[5]Esiashvili N, Goodman M, Marcus RB, Jr.: Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. Journal of pediatric hematology/oncology 2008, 30(6):425-430.EsiashviliNGoodmanMMarcusRB, Jr.Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results dataJournal of pediatric hematology/oncology200830642543010.1097/MPH.0b013e31816e22f318525458Search in Google Scholar

[6]Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. The New England journal of medicine 2003, 348(8):694-701.GrierHEKrailoMDTarbellNJLinkMPFryerCJPritchardDJGebhardtMCDickmanPSPerlmanEJMeyersPAAddition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of boneThe New England journal of medicine2003348869470110.1056/NEJMoa02089012594313Search in Google Scholar

[7]Benedetti MG, Bonatti E, Malfitano C, Donati D: Comparison of allograft-prosthetic composite reconstruction and modular prosthetic replacement in proximal femur bone tumors: functional assessment by gait analysis in 20 patients. Acta orthopaedica 2013, 84(2):218-223.BenedettiMGBonattiEMalfitanoCDonatiDComparison of allograft-prosthetic composite reconstruction and modular prosthetic replacement in proximal femur bone tumors: functional assessment by gait analysis in 20 patientsActa orthopaedica201384221822310.3109/17453674.2013.773119363934623597115Search in Google Scholar

[8]Stish BJ, Ahmed SK, Rose PS, Arndt CA, Laack NN: Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing Sarcoma. Pediatric blood & cancer 2015, 62(12):2189-2196.StishBJAhmedSKRosePSArndtCALaackNNPatient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing SarcomaPediatric blood & cancer201562122189219610.1002/pbc.25710543475926275239Search in Google Scholar

[9]Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM et al: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23(9):2004-2011.MeyersPASchwartzCLKrailoMKleinermanESBetcherDBernsteinMLConradEFergusonWGebhardtMGoorinAMOsteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexateJournal of clinical oncology : official journal of the American Society of Clinical Oncology20052392004201110.1200/JCO.2005.06.03115774791Search in Google Scholar

[10]Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J et al: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children’s Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27(15):2536-2541.GranowetterLWomerRDevidasMKrailoMWangCBernsteinMMarinaNLeaveyPGebhardtMHealeyJDose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children’s Oncology Group StudyJournal of clinical oncology : official journal of the American Society of Clinical Oncology200927152536254110.1200/JCO.2008.19.1478268485619349548Search in Google Scholar

[11]Davis AM, Wright JG, Williams JI, Bombardier C, Grifin A, Bell RS: Development of a measure of physical function for patients with bone and soft tissue sarcoma. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996, 5(5):508-516.DavisAMWrightJGWilliamsJIBombardierCGrifinABellRSDevelopment of a measure of physical function for patients with bone and soft tissue sarcomaQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation19965550851610.1007/BF005400248973131Search in Google Scholar

[12]Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clinical orthopaedics and related research 1993(286):241-246.EnnekingWFDunhamWGebhardtMCMalawarMPritchardDJA system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal systemClinical orthopaedics and related research199328624124610.1097/00003086-199301000-00035Search in Google Scholar

[13]Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL: Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 2008, 121(6):e1470-1477.LiJThompsonTDMillerJWPollackLAStewartSLCancer incidence among children and adolescents in the United States, 2001-2003Pediatrics20081216e1470147710.1542/peds.2007-296418519450Search in Google Scholar

[14]Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, Sripaiboonkij N: Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pacific journal of cancer prevention : APJCP 2011, 12(9):2215-2220.WiangnonSVeerakulGNuchprayoonISeksarnPHongengSKrutvechoTSripaiboonkijNChildhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology GroupAsian Pacific journal of cancer prevention : APJCP201112922152220Search in Google Scholar

[15]Lietman SA, Joyce MJ: Bone sarcomas: Overview of management, with a focus on surgical treatment considerations. Cleveland Clinic journal of medicine 2010, 77 Suppl 1:S8-12.LietmanSAJoyceMJBone sarcomas: Overview of management, with a focus on surgical treatment considerationsCleveland Clinic journal of medicine201077Suppl1S81210.3949/ccjm.77.s1.0220179186Search in Google Scholar

[16]Choi EY, Gardner JM, Lucas DR, McHugh JB, Patel RM: Ewing sarcoma. Seminars in diagnostic pathology 2014, 31(1):39-47.ChoiEYGardnerJMLucasDRMcHughJBPatelRMEwing sarcomaSeminars in diagnostic pathology2014311394710.1053/j.semdp.2014.01.00224680181Search in Google Scholar

[17]Widhe B, Widhe T: Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. The Journal of bone and joint surgery American volume 2000, 82(5):667-674.WidheBWidheTInitial symptoms and clinical features in osteosarcoma and Ewing sarcomaThe Journal of bone and joint surgery American volume200082566767410.2106/00004623-200005000-0000710819277Search in Google Scholar

[18]Nakamura T, Grimer RJ, Gaston CL, Watanuki M, Sudo A, Jeys L: The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone. The bone & joint journal 2013, 95-B(3):411-418.NakamuraTGrimerRJGastonCLWatanukiMSudoAJeysLThe prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of boneThe bone & joint journal201395-B341141810.1302/0301-620X.95B3.3034423450030Search in Google Scholar

[19]Arndt CA, Rose PS, Folpe AL, Laack NN: Common musculoskeletal tumors of childhood and adolescence. Mayo Clinic proceedings 2012, 87(5):475-487.ArndtCARosePSFolpeALLaackNNCommon musculoskeletal tumors of childhood and adolescenceMayo Clinic proceedings201287547548710.4016/47870.01Search in Google Scholar

[20]Moore DD, Haydon RC: Ewing’s sarcoma of bone. Cancer treatment and research 2014, 162:93-115.MooreDDHaydonRCEwing’s sarcoma of boneCancer treatment and research20141629311510.1007/978-3-319-07323-1_525070232Search in Google Scholar

[21]Moore DD, Luu HH: Osteosarcoma. Cancer treatment and research 2014, 162:65-92.MooreDDLuuHHOsteosarcomaCancer treatment and research2014162659210.1007/978-3-319-07323-1_425070231Search in Google Scholar

[22]Tunn PU, Pomraenke D, Goerling U, Hohenberger P: Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours-a comparative analysis using the MSTS score, the TESS and the RNL index. International orthopaedics 2008, 32(5):619-625.TunnPUPomraenkeDGoerlingUHohenbergerPFunctional outcome after endoprosthetic limb-salvage therapy of primary bone tumours-a comparative analysis using the MSTS score, the TESS and the RNL indexInternational orthopaedics200832561962510.1007/s00264-007-0388-8255171317701173Search in Google Scholar

[23]Aksnes LH, Bauer HC, Jebsen NL, Folleras G, Allert C, Haugen GS, Hall KS: Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. The Journal of bone and joint surgery British volume 2008, 90(6):786-794.AksnesLHBauerHCJebsenNLFollerasGAllertCHaugenGSHallKSLimb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patientsThe Journal of bone and joint surgery British volume200890678679410.1302/0301-620X.90B6.1980518539673Search in Google Scholar

[24]Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP et al: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012, 30(33):4148-4154.WomerRBWestDCKrailoMDDickmanPSPawelBRGrierHEMarcusKSailerSHealeyJHDormansJPRandomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical Oncology201230334148415410.1200/JCO.2011.41.5703349483823091096Search in Google Scholar

[25]Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kuhne T, Maas R et al: Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27(4):557-565.BielackSSKempf-BielackBBranscheidDCarrleDFriedelGHelmkeKKevricMJundtGKuhneTMaasRSecond and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patientsJournal of clinical oncology : official journal of the American Society of Clinical Oncology200927455756510.1200/JCO.2008.16.230519075282Search in Google Scholar